Introduction: Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) was first detected in December 2019 the city of Wuhan, China, and has since taken on worldwide proportions. It is known that individuals with Coronavirus disease-19 (COVID-19) have systemic clinical manifestations. Among multisystemic effects, cerebral venous thrombosis (CVT) responsible for high mortality rates. In this...

This study is to explore and evaluate the efficacy and safety of local thrombolytic therapy in superior sagittal sinus in patients with severe cerebral venous sinus thrombosis during puerperium, as well as the efficacy and safety of anti-platelet aggregation treatment for preventing recurrence. Twelve patients during postpartum period with cerebral venous sinus thrombosis were received local th...

Cerebral venous thrombosis (CVT) is infrequent among cerebrovascular diseases. The simultaneous thrombosis involving both cerebral artery and venous sinus is even extremely rare. We reported a 41-year-old woman who presented with acute headache and left hemiparesis due to concomitant arterial ischemic stroke and recurrent CVT. Extensive investigation disclosed acquired protein C and protein S d...

BACKGROUND AND PURPOSE Although intracerebral hemorrhages are frequent in patients with cerebral venous thrombosis, and lead to worse outcome, predictors of outcome in cerebral venous thrombosis patients with intracerebral hemorrhages have never been evaluated in adequately powered studies. METHODS This study was conducted as a part of the International Study on Cerebral Vein and Dural Sinus ...

Thrombosis of the deep cerebral venous system in the absence of superficial sinus thrombosis is a very rare disease. The clinical and radiological findings can be diagnostically challenging due to the subtle appearances on computed tomography (CT) scan. Magnetic resonance imaging (MRI) examination is a preferred imaging modality to complement the CT findings for an accurate diagnosis of venous ...

background: sildenafil is a selective inhibitor of phosphodiesterase type 5 (pde5) which currently used for the treatment of erection dysfunction (ed). medicine approved by the fda for treatment of pulmonary hypertension. although there is no evidence of hypercoagulation states being associated with the use of pde5 inhibitors, several animal studies suggest that pde5 inhibitors may cause arteri...

The first suggestion that oral contraception might be responsible for cerebral vascular disease was made by Lorentz (1962), when he described the case of a young woman who had been taking the contraceptive pill norethynodrel (Enavid) and had developed a left parietal vascular lesion. Other authors subsequently reported similar cases. Walsh et al. (1965) were the first to prove that the underlyi...

Cerebral sinus venous thrombosis is an uncommon cause of stroke. Three factors usually predispose to venous thrombosis: hypercoagulability states, venous stasis, and blood vessel wall changes.1--3 In patients with thyrotoxicosis, the increased activity of factor VIII,4 amongst others, results in a hypercoagulability state and has been reported as being a factor which predisposes to cerebral sin...

Cerebral sinus venous thrombosis is an uncommon cause of stroke. Three factors usually predispose to venous thrombosis: hypercoagulability states, venous stasis, and blood vessel wall changes.1--3 In patients with thyrotoxicosis, the increased activity of factor VIII,4 amongst others, results in a hypercoagulability state and has been reported as being a factor which predisposes to cerebral sin...

Cerebral sinus venous thrombosis is an uncommon cause of stroke. Three factors usually predispose to venous thrombosis: hypercoagulability states, venous stasis, and blood vessel wall changes.1--3 In patients with thyrotoxicosis, the increased activity of factor VIII,4 amongst others, results in a hypercoagulability state and has been reported as being a factor which predisposes to cerebral sin...